Protagenic Therapeutics (PTIX) News Today → Millionaire Investor makes surprising election prediction (From InvestorPlace) (Ad) Free PTIX Stock Alerts $1.50 +0.01 (+0.67%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 17, 2024 | finanznachrichten.deProtagenic Therapeutics, Inc.: Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston SummitApril 17, 2024 | finance.yahoo.comProtagenic Therapeutics’ Innovative Peptide PT00114 to be Highlighted at Boston SummitApril 2, 2024 | msn.comProtagenic Therapeutics, Inc. (NASDAQ:PTIX) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | finance.yahoo.comProtagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric DisordersMarch 25, 2024 | finanznachrichten.deProtagenic Therapeutics, Inc.: Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings CallFebruary 13, 2024 | finance.yahoo.comProtagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related DisordersJanuary 4, 2024 | marketbeat.comTrading was temporarily halted for "PTIX" at 02:01 PM with a stated reason of "LULD pause."December 17, 2023 | morningstar.comProtagenic Therapeutics Inc PTIXNovember 14, 2023 | seekingalpha.comPTIX Protagenic Therapeutics, Inc.October 13, 2023 | finanznachrichten.deProtagenic Therapeutics, Inc.: Protagenic Therapeutics Announces Date of Annual Shareholder MeetingOctober 13, 2023 | finance.yahoo.comProtagenic Therapeutics Announces Date of Annual Shareholder MeetingSeptember 26, 2023 | finanznachrichten.deProtagenic Therapeutics, Inc.: Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114September 26, 2023 | finance.yahoo.comProtagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114June 17, 2023 | uk.finance.yahoo.comPTIX - Protagenic Therapeutics, Inc.March 24, 2023 | benzinga.comProtagenic Therapeutics Stock (NASDAQ:PTIX), DividendsMarch 22, 2023 | finanznachrichten.deProtagenic Therapeutics, Inc.: Protagenic Therapeutics to Effect 1-for-4 Reverse Stock SplitMarch 22, 2023 | finance.yahoo.comProtagenic Therapeutics to Effect 1-for-4 Reverse Stock SplitSeptember 7, 2022 | investing.comPTIX_old Historical DataAugust 12, 2022 | finance.yahoo.comProtagenic Therapeutics, Inc. (PTIX)April 26, 2022 | finance.yahoo.comProtagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27thJanuary 20, 2022 | nasdaq.comProtagenic Therapeutics, Inc. Common Stock (PTIX)November 16, 2021 | finance.yahoo.comProtagenic Therapeutics Announces Third Quarter 2021 Results and Business UpdateAugust 30, 2021 | finance.yahoo.comProtagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ETAugust 17, 2021 | finance.yahoo.comProtagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business UpdateJuly 23, 2021 | marketwatch.comProtagenic Therapeutics Updates on Patient Enrollment for PT00114 Trial, Shares LowerJuly 23, 2021 | apnews.comProtagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 ...July 23, 2021 | finance.yahoo.comProtagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial Get Protagenic Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter. Email Address The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made … Click here to see the presentation now. PTIX Media Mentions By Week PTIX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTIX News Sentiment▼0.000.50▲Average Medical News Sentiment PTIX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTIX Articles This Week▼00▲PTIX Articles Average Week Get Protagenic Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sonnet BioTherapeutics News Genprex News Hoth Therapeutics News Lipella Pharmaceuticals News Adial Pharmaceuticals News Kineta News Synaptogenix News Lixte Biotechnology News Enveric Biosciences News First Wave BioPharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PTIX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceI’m afraid WWIII is a very real possibility Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagenic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
